These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8067751)

  • 21. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.
    Henquell C; Chanal C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 1995 Feb; 39(2):427-30. PubMed ID: 7726509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.
    Robin F; Delmas J; Archambaud M; Schweitzer C; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2403-8. PubMed ID: 16801418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    J Antimicrob Chemother; 1989 Aug; 24(2):103-10. PubMed ID: 2676935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.
    Thomson CJ; Amyes SG
    Epidemiol Infect; 1993 Feb; 110(1):117-25. PubMed ID: 8432315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
    Ourghanlian C; Soroka D; Arthur M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain.
    Thomson CJ; Amyes SG
    FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1989 May; 50(1-2):97-100. PubMed ID: 2661324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
    Lemozy J; Sirot D; Chanal C; Huc C; Labia R; Dabernat H; Sirot J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2580-2. PubMed ID: 8585751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.
    Vakulenko SB; Tóth M; Taibi P; Mobashery S; Lerner SA
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1878-80. PubMed ID: 7486939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
    Helfand MS; Bethel CR; Hujer AM; Hujer KM; Anderson VE; Bonomo RA
    J Biol Chem; 2003 Dec; 278(52):52724-9. PubMed ID: 14534312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R164H and V240H replacements by site-directed mutagenesis of TEM-149 extended-spectrum β-lactamase: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants.
    Perilli M; Celenza G; Mercuri PS; Galleni M; Pellegrini C; Segatore B; Amicosante G
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1047-9. PubMed ID: 23183431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
    Robin F; Delmas J; Brebion A; Dubois D; Constantin JM; Bonnet R
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4181-3. PubMed ID: 17709463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.